The 19-year-old phenom, who is set to finally take over as a starter in the 2025 season, said he has been bullied by his famous uncles, Peyton and Eli, and they have even given him wedgies.

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Eli Manning will have to wait to get into the Pro Football Hall of Fame for at least another year. The legendary New York Giants quarterback didn't make the cut for the Class of 2025 in his first ...

It was an honor many thought would go to Peyton and Eli Manning, who missed out on the Hall of Fame Tuesday night. "Sterling and Shannon Sharpe are the first brothers to both be inducted into the ...

Eli Lilly (LLY) stock is higher Thursday after the pharmaceutical company beat profit expectations and matched revenue forecasts for its fourth quarter and issued a better-than-expected outlook ...

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...

It’s the smallest Hall of Fame class in 20 years. Not making the cut: Eli Manning. The former New York Giants quarterback, a two-time Super Bowl MVP, was bypassed by the 49-member selection ...

Global pharmaceutical company Eli Lilly's (LLY) preliminary 2024 revenue missed expectations on lower-than-expected sales of its weight loss and diabetes shots. According to the company ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

Voters frowned on Eli Manning’s .500 regular-season record and looked past his two Super Bowl wins in denying him – for now, at least – a place in Canton. Manning was a finalist but is ...